Decentralized trial technology center stage at online event
The drug development industry had dipped its collective toe into the decentralized trials before COVID-19 disrupted clinical trials. However, the disruption caused by the global pandemic meant that professionals needed to take a deeper dive into DCTs in order to keep research afloat.
Taking clinical studies from a trial site to offsite is more than chancing the geography and scenery. In order to launch a DCT, or make the change from site to patient homes, trial teams need to consider study design, state-of-the-art data collection and management tools, advanced patient engagement technology, and more.
If you’re interested in hearing more about the recipe for DCT success, join us for Outsourcing-Pharma's upcoming webinar on Decentralized Trial Technology. Your registration to this exclusive online event entitles you to listen in on insights shared by a group of leading industry experts:
- Josh Rose, CVS Health Clinical Trial Services
- Walter Stadler, University of Chicago Medicine
- Mohammed Ali, Association of Clinical Research Professionals.
This dynamic webinar is broadcasting live on July 20 at 10 am CST. In one hour, our presenters will pack in a wealth of knowledge about DCT tools and techniques, and what advances might be on the horizon.
We are happy to have the generous support of two sponsors, who have helped make this intensive chat about DCT challenges and opportunities possible:
Click here to register today—and feel free to share the sign-up link with colleagues who might benefit from the lively discussion. If you're busy and can't join us at the scheduled date and time, don't worry - your registration enables you to go back and view the webinar at your convenience, as soon as the recording is available.